IDDI LUNCH & LEARN WORKSHOP

October 8, 2019 — October 8, 2019

Museum of Science, Boston, MA

Validating Surrogate Endpoints in Oncology: From Theory to Practice!

IF YOU MISSED OUR LUNCH & LEARN ON VALIDATING SURROGATE ENDPOINTS IN ONCOLOGY, PRESENTATIONS AND RECORDING ARE AVAILABLE HERE :

	A clinical perspective on surrogate endpoints in prostate cancer Prof Christopher Sweeney, MBBS, Professor of Medicine, Harvard Medical School and Medical Oncologist, Dana-Farber Cancer Institute	PRESENTATION: Lunch & Learn: Prof. Christopher Sweeney
	Statistical considerations on surrogate endpoints Prof Tomasz Burzykowski, PhD, VP Research IDDI and Professor of Biostatistics, Hasselt University, Belgium	PRESENTATION: Lunch & Learn: Prof Tomasz Burzykowski
VIEW THE RECORDING HERE

WHAT YOU WILL LEARN:

• The theoretical requirements for validating surrogate endpoints, as currently used by FDA
• The steps entailed in surrogate validation
• The difference between patient-level and trial-level surrogacy